ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,397Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 3001

$1.91M Total Retail Price of All Prescriptions

Rank: 16 out of 3001

690 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 690 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 20,791 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 926 775 1 1
FUROSEMIDE 918 821 2 6
OMEPRAZOLE 685 541 3 4
LEVOTHYROXINE SODIUM 633 551 4 3
LISINOPRIL 549 500 5 2
DONEPEZIL HCL 482 433 6 27
METFORMIN HCL 438 379 7 9
GABAPENTIN 431 349 8 14
NAMENDA 394 394 9 40
WARFARIN SODIUM 387 322 10 12
TRAMADOL HCL 328 257 11 17
BISOPROLOL-HYDROCHLOROTHIAZIDE 290 261 12 111
METOPROLOL TARTRATE 278 235 13 8
AMLODIPINE BESYLATE 269 244 14 5
ATORVASTATIN CALCIUM 267 204 15 11
OLANZAPINE 257 177 16 106
CITALOPRAM HBR 254 229 17 16
JANUVIA 253 224 18 54
SERTRALINE HCL 248 173 19 20
ACTOS 241 211 20 113
CRESTOR 240 197 21 33
CLOPIDOGREL 240 226 21 28
HYDROCODONE-ACETAMINOPHEN 238 208 S3 23 7
MIRTAZAPINE 237 224 24 44
FLUOXETINE HCL 236 220 25 61
CARVEDILOL 236 207 25 25
ESCITALOPRAM OXALATE 227 192 27 82
ALENDRONATE SODIUM 217 189 28 26
DIVALPROEX SODIUM 211 124 29 70
POTASSIUM CHLORIDE 207 173 30 15
NEXIUM 192 106 31 23
CIPROFLOXACIN HCL 188 166 32 56
METHADONE HCL 181 109 S2 33 163
NIASPAN 180 136 34 133
LOSARTAN POTASSIUM 176 164 35 21
BUSPIRONE HCL 176 120 35 91
CYMBALTA 174 129 37 53
PLAVIX 167 138 38 46
EXELON 166 166 39 108
SEROQUEL XR 165 142 40 197
RISPERIDONE 161 141 41 63
FENTANYL 158 147 S2 42 76
TAMSULOSIN HCL 156 121 43 29
OXYCODONE-ACETAMINOPHEN 155 86 S2 44 32
DIGOXIN 154 154 45 65
HYDROCHLOROTHIAZIDE 154 136 45 10
LANTUS 153 141 47 47
FENOFIBRATE 151 95 48 59
ALLOPURINOL 151 138 48 35
PAROXETINE HCL 150 112 50 60
AZITHROMYCIN 148 107 51 36
KLOR-CON M20 142 121 52 52
QUETIAPINE FUMARATE 141 92 53 66
POLYETHYLENE GLYCOL 3350 133 124 54 55
MELOXICAM 133 102 54 34
SPIRIVA 127 92 56 57
CILOSTAZOL 124 123 57 224
TRAZODONE HCL 122 90 58 37
PIOGLITAZONE HCL 117 100 R 59 274
METOPROLOL SUCCINATE 115 96 60 19
AMILORIDE HCL 113 95 10 61 422
CARBIDOPA-LEVODOPA 111 107 62 97
PANTOPRAZOLE SODIUM 110 80 63 43
PREDNISONE 107 92 64 39
OXYCODONE HCL 104 45 S2 65 72
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 66 65 77
VENLAFAXINE HCL ER 102 81 67 103
DIOVAN 102 91 67 50
PRAVASTATIN SODIUM 101 86 69 13
ATENOLOL 100 96 70 18
ZETIA 99 91 71 69
LIDODERM 95 68 72 122
ABILIFY 95 76 72 144
PROAIR HFA 95 63 72 30
AMLODIPINE BESYLATE-BENAZEPRIL 92 85 75 78
LOVASTATIN 92 92 75 38
CELEBREX 90 65 77 89
RANITIDINE HCL 89 61 78 41
ROPINIROLE HCL 87 86 79 88
LYRICA 87 44 79 87
NITROFURANTOIN MONO-MACRO 85 75 81 158
CEFDINIR 85 75 81 221
ZOLPIDEM TARTRATE 84 59 83 24
TOPIRAMATE 84 48 83 156
LEXAPRO 83 69 85 222
NOVOLOG 79 73 86 94
WELCHOL 79 62 86 235
VESICARE 79 57 86 244
NIFEDIPINE ER 77 72 89 154
DILTIAZEM 24HR CD 76 63 90 124
LOSARTAN-HYDROCHLOROTHIAZIDE 75 63 91 49
CEPHALEXIN 75 61 91 86
CYCLOBENZAPRINE HCL 74 29 R 93 73
TRAMADOL HCL-ACETAMINOPHEN 74 67 93 210
SYMBICORT 74 46 93 155
CARBAMAZEPINE 73 32 96 134
LEVETIRACETAM 71 30 97 112
BUPROPION XL 71 53 97 176
GLIMEPIRIDE 71 61 97 31
SODIUM CHLORIDE 69 18 100 199
FAMOTIDINE 68 47 101 68
ADVAIR DISKUS 65 52 102 58
PHENYTOIN SODIUM EXTENDED 65 39 102 126
TIZANIDINE HCL 63 56 104 101
SPIRONOLACTONE 62 58 105 75
THEOPHYLLINE ANHYDROUS 62 62 105 212
LOVAZA 61 58 107 168
OXYBUTYNIN CHLORIDE ER 60 45 108 79
VENLAFAXINE HCL 58 48 109 171
RANEXA 58 55 109 452
DIVALPROEX SODIUM ER 58 39 109 142
CLONIDINE HCL 55 42 112 64
LIPITOR 54 47 113 100
AMOX TR-POTASSIUM CLAVULANATE 54 39 113 143
LEVOFLOXACIN 54 49 113 115
SOTALOL 52 52 116 266
LAMOTRIGINE 51 51 117 145
TRANDOLAPRIL 51 48 117 564
SANTYL 51 50 117 273
CLOZAPINE 51 43 117 170
FLUTICASONE PROPIONATE 50 40 121 42
SEROQUEL 50 43 121 146
GENTAMICIN SULFATE 50 44 121 277
AMOXICILLIN 50 43 121 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.